Cognitive and motor assessment in autopsy-proven corticobasal degeneration

Objective: To investigate the clinical features of autopsy-proven corticobasal degeneration (CBD). Methods: We evaluated symptoms, signs, and neuropsychological deficits longitudinally in 15 patients with autopsy-proven CBD and related these observations directly to the neuroanatomic distribution of disease. Results: At presentation, a specific pattern of cognitive impairment was evident, whereas an extrapyramidal motor abnormality was present in less than half of the patients. Follow-up examination revealed persistent impairment of apraxia and executive functioning, worsening language performance, and preserved memory. The motor disorder emerged and worsened as the condition progressed. Statistical analysis associated cognitive deficits with tau-immunoreactive pathology that is significantly more prominent in frontal and parietal cortices and the basal ganglia than temporal neocortex and the hippocampus. Conclusion: The clinical diagnosis of corticobasal degeneration should depend on a specific pattern of impaired cognition as well as an extrapyramidal motor disorder, reflecting the neuroanatomic distribution of disease in frontal and parietal cortices and the basal ganglia.

[1]  Murray Grossman,et al.  Left Inferior Parietal Representations for Skilled Hand-Object Interactions: Evidence from Stroke and Corticobasal Degeneration , 2007, Cortex.

[2]  W. Sturm,et al.  Neuropsychological assessment , 2007, Journal of Neurology.

[3]  Jennifer Farmer,et al.  Frontotemporal dementia: Clinicopathological correlations , 2006, Annals of neurology.

[4]  Joseph James Duffy,et al.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.

[5]  M. Edwards,et al.  Secondary generalized dystonia without basal ganglia damage. , 2005, Parkinsonism & related disorders.

[6]  Maria Luisa Gorno-Tempini,et al.  Clinical, Cognitive and Anatomical Evolution from Nonfluent Progressive Aphasia to Corticobasal Syndrome: A Case Report , 2004, Neurocase.

[7]  J. Gee,et al.  Dissociation of numbers and objects in corticobasal degeneration and semantic dementia , 2004, Neurology.

[8]  M. Doran,et al.  Language function and dysfunction in corticobasal degeneration , 2004, Neurology.

[9]  G. Giovannoni,et al.  The clinical significance of an intrathecal monoclonal immunoglobulin band A follow-up study , 2004 .

[10]  J. Gee,et al.  What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. , 2003, Brain : a journal of neurology.

[11]  W. Paulus,et al.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles , 2004, Acta Neuropathologica.

[12]  Howard J. Rosen,et al.  Distinctive Neuropsychological Patterns in Frontotemporal Dementia, Semantic Dementia, And Alzheimer Disease , 2003, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[13]  J. Hodges,et al.  Corticobasal degeneration as a cognitive disorder , 2003, Movement disorders : official journal of the Movement Disorder Society.

[14]  B. Boeve,et al.  Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction , 2003, Neurology.

[15]  I. McKeith,et al.  SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.

[16]  P. Lantos,et al.  Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.

[17]  Murray Grossman,et al.  Signature tau neuropathology in gray and white matter of corticobasal degeneration. , 2002, The American journal of pathology.

[18]  K. Dujardin,et al.  Neural and cognitive bases of upper limb apraxia in corticobasal degeneration , 2001, Neurology.

[19]  K. Marder,et al.  Cortical basal ganglionic degeneration. , 2001, Science of aging knowledge environment : SAGE KE.

[20]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[21]  L. Hakamies,et al.  [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.

[22]  J. Ridley.  Studies of Interference in Serial Verbal Reactions , 2001 .

[23]  A. Kertesz,et al.  The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia , 2000, Neurology.

[24]  E. Kaplan,et al.  Visuoconstructional problems in dementia: contribution of executive systems functions. , 2000, Neuropsychology.

[25]  N. Cairns,et al.  Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. , 2000, Clinical neuropathology.

[26]  J R Hodges,et al.  Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  M. Grisoli,et al.  Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. , 2000, Advances in neurology.

[28]  A. Lang,et al.  Clinical diagnostic criteria. , 2000, Advances in neurology.

[29]  A. Lang,et al.  Dementia as the most common presentation of cortical-basal ganglionic degeneration , 1999, Neurology.

[30]  R. Petersen,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[31]  D. Radice,et al.  Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy , 1999, Neurology.

[32]  M. Mega,et al.  Neuropsychiatric features of corticobasal degeneration , 1998, Journal of neurology, neurosurgery, and psychiatry.

[33]  C. Marsden,et al.  Clinical presentation and pharmacological therapy in corticobasal degeneration. , 1998, Archives of neurology.

[34]  I Litvan,et al.  Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination , 1998, Journal of neurology, neurosurgery, and psychiatry.

[35]  P. Ashby,et al.  Reflex myoclonus in cortical‐basal ganglionic degeneration involves a transcortical pathway , 1997, Movement disorders : official journal of the Movement Disorder Society.

[36]  M. Albert,et al.  Corticobasal degeneration: neuropsychological and clinical correlates. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[37]  M. D’Esposito,et al.  Language comprehension profiles in Alzheimer's disease, multi-infarct dementia, and frontotemporal degeneration , 1996, Neurology.

[38]  R. Doody,et al.  Neuropsychological functioning in cortical-basal ganglionic degeneration , 1996, Neurology.

[39]  D. Dickson,et al.  Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.

[40]  A. Sirigu,et al.  The neuropsychological pattern of corticobasal degeneration , 1995, Neurology.

[41]  A. Kertesz,et al.  The pathology and nosology of primary progressive aphasia , 1994, Neurology.

[42]  C D Marsden,et al.  Corticobasal degeneration: A clinical study of 36 cases , 1994 .

[43]  C. Marsden,et al.  The behavioural and motor consequences of focal lesions of the basal ganglia in man. , 1994, Brain : a journal of neurology.

[44]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[45]  N Butters,et al.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. , 1992, Archives of neurology.

[46]  Y Agid,et al.  Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET , 1992, Movement disorders : official journal of the Movement Disorder Society.

[47]  J R Moeller,et al.  The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[48]  N Butters,et al.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.

[49]  C D Marsden,et al.  Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. , 1991, Brain : a journal of neurology.

[50]  P. Ashby,et al.  Cortical‐basal ganglionic degeneration , 1990, Neurology.

[51]  Robert A. Bornstein,et al.  The Wechsler Memory Scale—Revised , 1990 .

[52]  J. Coyle,et al.  Cortical Degeneration with Swollen Chromatolytic Neurons: Its Relationship to Pick's Disease , 1986, Journal of neuropathology and experimental neurology.

[53]  E. Kaplan,et al.  The Boston naming test , 2001 .

[54]  J. Constantinidis,et al.  Pick’s Disease , 1974 .

[55]  R. Tissot,et al.  Pick's disease. Histological and clinical correlations. , 1974, European neurology.

[56]  E. Richardson,et al.  Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.